文献速递肝病

空腹酮尿与非糖尿病人群新发非酒精性脂肪肝及肝纤维化风险

Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

在153,076名无脂肪肝且纤维化低概率的非糖尿病韩国成人中随访中位4.1年,空腹酮尿与新发肝脂肪变风险降低相关(多变量调整HR 0.81,95%CI 0.78-0.84),与中高NFS的肝脂肪变风险降低也相关(HR 0.79,95%CI 0.69-0.90)。持续酮尿者风险降低最明显。

要点

  • 非糖尿病健康成人中,空腹酮尿与新发肝脂肪变风险降低独立相关。
  • 酮尿与中高NFS或FIB-4提示的肝脂肪变风险降低同样相关。
  • 基线和随访均持续酮尿者,新发NAFLD风险降低幅度最大。

核心结论

  • 在非糖尿病健康人群中,酮尿与新发肝脂肪变(伴或不伴中高概率进展性纤维化)风险降低相关。
  • 高酮血症在预防NAFLD中的作用仍需进一步探索。

研究设计与样本

  • 队列研究,纳入153,076名基线无肝脂肪变且纤维化低概率的非糖尿病韩国成人,随访中位4.1年。
  • 结局为新发肝脂肪变伴或不伴肝纤维化,通过肝脏超声和无创纤维化指标(FIB-4和NFS)评估。
  • 采用参数比例风险模型估计酮尿状态对应结局的风险比(HR)。

主要发现

  • 随访677,702.1人年期间,31,079人发生肝脂肪变。
  • 与无酮尿相比,空腹酮尿与新发肝脂肪变风险降低显著相关,多变量调整HR为0.81(95%CI 0.78-0.84)。
  • 中高NFS的新发肝脂肪变对应HR为0.79(95%CI 0.69-0.90);以FIB-4替代NFS观察到相似关联。
  • 基线和后续访视均持续酮尿者,新发NAFLD的调整HR降低幅度最大。

临床怎么用

  • 在非糖尿病成人中,空腹酮尿可能提示新发NAFLD风险较低,可作为风险分层参考。
  • 持续酮尿与新发NAFLD风险降低幅度最大相关,动态监测酮尿状态或有参考价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Dietary carbohydrate restriction or ketogenic diets are known to be beneficial in preventing liver fat accumulation. However, the effect of ketonemia on the risk of nonalcoholic fatty liver disease (NAFLD) in nondiabetic population is largely unknown. We investigated the association between fasting ketonuria and the risk of incident NAFLD in healthy adults. METHODS: A cohort of 153,076 nondiabetic Koreans with no hepatic steatosis and low probability of fibrosis at baseline was followed for a median of 4.1 years. The outcome was incident hepatic steatosis with or without liver fibrosis, and it was assessed by liver ultrasound and noninvasive fibrosis indices, including fibrosis-4 and the NAFLD fibrosis score (NFS). Parametric proportional hazard models were used to estimate hazard ratios (HRs) for outcome according to ketonuria status. RESULTS: Within 677,702.1 person-years of follow-up, 31,079 subjects developed hepatic steatosis. Compared with no ketonuria (reference), fasting ketonuria was significantly associated with a decreased risk of incident hepatic steatosis, with multivariable-adjusted HRs (95% confidence interval) of 0.81 (0.78-0.84). The corresponding HRs for incident hepatic steatosis with intermediate-to-high NFS were 0.79 (0.69-0.90). Similar associations were observed replacing NFS with fibrosis-4. In addition, the presence of persistent ketonuria at both baseline and subsequent visit was associated with the greatest decrease in the adjusted HR for incident NAFLD. DISCUSSION: Ketonuria was associated with a reduced risk of developing incident hepatic steatosis with and without intermediate-to-high probability of advanced fibrosis in a large cohort of nondiabetic healthy individuals. The role of hyperketonemia in the prevention of NAFLD requires further exploration.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kim Y, Chang Y, Kwon MJ, et al. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults. Am J Gastroenterol. 2021. PMID: 34114568. doi:10.14309/ajg.0000000000001344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。